Navigating the Nuances: Australia’s Mandatory Mental Health Screening in Cosmetic Procedures
In the pursuit of aesthetic enhancement, Australians are now embarking on a journey that extends beyond the operating theatre and into the realm of psychological well-being. For nearly three years, a significant shift has occurred within the nation’s cosmetic industry, with mandatory mental health screening becoming a standard prerequisite for a wide array of cosmetic procedures. This initiative, spearheaded by the Australian Health Practitioner Regulation Agency (AHPRA), encompasses everything from invasive surgical interventions like facelifts to less invasive treatments such as cosmetic injections and laser therapies.
This regulatory overhaul is part of a broader strategy to bolster patient safety, positioning Australia at the forefront of tightly regulated cosmetic markets globally. With these reforms firmly in place, a critical question arises: how effective have they been, and have patients genuinely benefited?
The Booming Business of Beauty: Cosmetic Medicine in Australia
The allure of cosmetic enhancement is undeniable, with Australians collectively investing over A$1 billion annually in more than half a million procedures. This per capita spending eclipses that of the United States, highlighting a significant national interest in aesthetic alterations. Projections suggest this trend will continue, with over a third of Australians contemplating cosmetic surgery within the next decade. This aspiration is particularly pronounced among younger women, where a striking 54% express interest in cosmetic surgery at some point in their lives. The primary drivers behind these decisions are typically the desire for improved appearance and a boost in self-esteem.
The outcomes for many are positive, with approximately 80-90% of patients reporting satisfaction with their cosmetic surgery results. Many continue to feel a positive impact on their appearance for up to five years post-procedure, with some studies even indicating improvements in mood and overall quality of life. However, the landscape isn’t universally rosy. A subset of patients may experience regret or a decline in their well-being following procedures, underscoring the critical need to identify vulnerable individuals, especially those considering irreversible changes.
The Intricate Link Between Cosmetic Surgery and Mental Health
The rationale behind incorporating mental health assessments into the cosmetic procedure pathway is firmly rooted in research. Studies consistently demonstrate that pre-operative psychological evaluations can significantly influence post-operative patient experiences. Individuals exhibiting heightened symptoms of psychological distress, such as anxiety and depression, are statistically more prone to dissatisfaction with surgical outcomes. They may also face a more challenging recovery period and a higher likelihood of experiencing post-operative complications.
Certain psychological conditions carry a particularly profound impact on a patient’s mental health trajectory after cosmetic surgery. Body dysmorphic disorder (BDD) stands out as a prime example. Sufferers of BDD often become fixated on perceived flaws in their appearance, which may be subtle or imperceptible to others. Consequently, they may view cosmetic surgery as a panacea for these perceived imperfections.
A comprehensive review of related studies in 2022 revealed that as many as 20% of patients seeking cosmetic procedures may have BDD. Further research conducted in 2025 indicated that approximately 12% of Australian cosmetic patients either harbour unrealistic expectations of cosmetic surgery or exhibit symptoms of BDD or general psychological distress.
The persistent dissatisfaction experienced by many with BDD post-treatment is a significant concern. This often stems from a continued focus on the original perceived flaw, or the emergence of new ones. Such experiences can detrimentally affect their mental health and, in some instances, may lead to legal disputes between patients and surgeons.
The Rationale Behind Mandatory Screening
The implementation of mandatory screening by AHPRA nearly three years ago marked a pivotal moment for the cosmetic industry. The revised guidelines compel practitioners to screen patients for psychological conditions like BDD, employing methods such as in-depth interviews or standardised questionnaires.
Should any concerns arise during this screening process, practitioners are obliged to refer patients to a psychologist, psychiatrist, or their General Practitioner (GP) for further assessment before proceeding with any cosmetic treatment.
However, a recent national survey suggests a lukewarm reception to these reforms within the industry. The findings indicated that a staggering 84% of plastic surgeons referred fewer than 5% of their patients for further psychological evaluation – a figure considerably lower than what would be expected based on the prevalence of conditions like BDD. Furthermore, approximately 70% of interviewed plastic surgeons stated they would cease screening practices if they were no longer mandatory.
This sentiment has not gone unnoticed, with some surgeons publicly voicing their concerns. In 2024, a group of surgeons even initiated legal proceedings against AHPRA, seeking to overturn the new guidelines or establish additional patient protections.
From a patient’s perspective, mandatory screening can present a barrier to accessing cosmetic surgery. A 2025 study involving over 8,000 Australian cosmetic patients revealed a marked reluctance among participants to disclose mental health symptoms in a clinical setting compared to when completing the same questionnaire anonymously for research purposes. This hesitancy is likely driven by the perception that they must “pass” psychological screening to be approved for surgery, highlighting a significant limitation in the current self-reporting mechanisms.
Assessing the Necessity and Efficacy of Psychological Screening
The fundamental objective of psychological screening in cosmetic medicine was never to outright deny individuals treatment. Instead, its purpose was to foster informed decision-making processes for both practitioners and patients.
It’s noteworthy that almost half of individuals considering cosmetic procedures report pre-existing mental health concerns. For the majority, these concerns do not render them unsuitable candidates. However, in specific cases, a temporary delay in undergoing a cosmetic procedure might be beneficial, allowing individuals time to seek additional psychological support or engage in more thorough discussions with practitioners about realistic expectations and potential outcomes.
Crucially, screening tools should not function in isolation. They should form an integral component of a comprehensive patient assessment, encompassing their motivations, goals, and overall well-being. This holistic approach includes a candid discussion about how cosmetic surgery might positively or negatively influence their mental health.
Researchers, including the authors, are actively developing novel screening questionnaires aimed at assisting surgeons in more accurately evaluating a patient’s psychological state and identifying potential concerns prior to cosmetic procedures. However, further research is imperative to ascertain the true impact of these advancements on patient and practitioner outcomes.
While discussing mental health with a cosmetic surgeon might initially feel uncomfortable, it serves as a vital safeguard. It helps ensure that decisions regarding aesthetic changes are made from a position of psychological stability rather than distress.
Toni Pikoos is a clinical psychologist and co-founder of ReadyMind, an organisation that provides psychological assessment and training tailored for cosmetic settings. She provided consultation during AHPRA’s review into cosmetic patient safety. She has received payment for speaking and consulting work from cosmetic pharmaceutical companies. Her research has previously been supported by an Australian government Research Training Program stipend.
Ben Buchanan is the co-director of ReadyMind, an organisation that conducts research at the intersection of mental health and cosmetic procedures, develops psychometric scales, and performs psychological assessments for these purposes.
